Muscarinic receptor subtypes in the medial preoptic area and sleep-wake cycles.
To clarify which muscarinic receptor subtype(s) mediate changes in sleep and cortical temperature (Tcort) induced by carbachol microinjections into the medial preoptic area (MPA), pirenzepine, tripitramine and +/- p < > -fluorohexahydro-sila-difenidol (p-F-HHSiD), which are highly selective muscarinic M1, M2 and M3 antagonists, respectively, were microinjected into the MPA of rats. Whereas pirenzepine (3.45 and 7.08 nmol) and p-F-HHSiD (3.90 and 7.80 nmol) were without effect, tripitramine (0.67 and 3.37 nmol) enhanced wakefulness, decreased slow wave and desynchronized sleep, and raised Tcort with the higher dose. The data suggest that in the MPA only M2 muscarinic subtypes may be functionally important in mediating the cholinergic effects on sleep and thermoregulation.
Imeri
L
L
Istituto di Fisiologia Umana II, Università delgi Studi, Milan, Italy.
Bianchi
S
S
Angeli
P
P
Mancia
M
M
D000818:Animals; D001569:Benzodiazepines / Q000008:administration & dosage / Q000494:pharmacology; D001833:Body Temperature Regulation / Q000187:drug effects; D008297:Male; D008845:Microinjections; D018727:Muscarinic Antagonists / Q000494:pharmacology*; D010880:Piperidines / Q000008:administration & dosage / Q000494:pharmacology; D010890:Pirenzepine / Q000008:administration & dosage / Q000494:pharmacology; D011301:Preoptic Area / Q000033:anatomy & histology / Q000502:physiology*; D051381:Rats; D011976:Receptors, Muscarinic / Q000502:physiology*; D012890:Sleep / Q000502:physiology*; D012895:Sleep, REM / Q000187:drug effects; D014851:Wakefulness / Q000502:physiology*
D018727:Muscarinic Antagonists; D010880:Piperidines; D011976:Receptors, Muscarinic; C058297:4-fluorohexahydrosiladifenidol; D001569:Benzodiazepines; C084480:tripitramine; D010890:Pirenzepine